title: Treatment of precocious puberty in McCune-Albright syndrome.
abstract: McCune-Albright syndrome (MAS) is typically defined as a triad of precocious puberty (PP), café au lait spots and fibrous dysplasia of bone. PP is the most common endocrinological manifestation of this rare disease and is much more common in girls than in boys. The treatment options for PP associated with MAS have evolved over the last twenty plus years. Therapy in girls typically includes the use of an anti-estrogen, while treatment options in boys include an antiandrogen in combination with an aromatase inhibitor (AI). This article will briefly review the older therapies and explain why they have largely been supplanted by newer approaches. We will discuss current pharmacotherapy options for the treatment of PP in MAS and finally describe potential novel therapies that will hopefully enable optimal care for affected patients.
authors.affiliation: Department of Pediatrics, Section of Endocrinology/Diabetology, James Whitcomb Riley Hospital for Children, Indiana University School of Medicine, Room 5960, 702 Barnhill Drive, Indianapolis, IN 46202, USA. jmieszcz@iupui.edu
authors.forename: Jakub
authors.initials: J
authors.lastname: Mieszczak
authors.forename: Erica A
authors.initials: EA
authors.lastname: Eugster
mesh_terms: D005359:Fibrous Dysplasia, Polyostotic / Q000150:complications*; D006801:Humans; D011629:Puberty, Precocious / Q000209:etiology* / Q000628:therapy*